title: Targeted therapy: an evolving concept in esophageal adenocarcinoma.
authors.affiliation: Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
authors.forename: Michael K
authors.initials: MK
authors.lastname: Gibson
authors.forename: Usha
authors.initials: U
authors.lastname: Malhotra
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors; D006801:Humans; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D042461:Vascular Endothelial Growth Factor A; D017228:Hepatocyte Growth Factor; D066246:ErbB Receptors; D017526:Receptor, IGF Type 1